Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies.
Taylor P, Chen Y, Pope J, Weinblatt M, Mysler E, Rubbert-Roth A, Jia B, Sun L, Liu Y, Holzkämper T, Tanaka Y. Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies. Rheumatol Ther 2023; 10:463-476.
20.01.2023
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies.
20.01.2023
Rheumatol Ther 2023; 10:463-476
Taylor Peter C, Chen Yun-Fei, Pope Janet E, Weinblatt Michael, Mysler Eduardo F, Rubbert-Roth Andrea, Jia Bochao, Sun Luna, Liu Yushi, Holzkämper Thorsten, Tanaka Yoshiya
Weiter
